This Inaugural conference will equip clinical leaders with actionable, evidence-based strategies to drive down device-associated infections, optimize antibiotic stewardship, and elevate frontline safety. Attendees will gain practical insights into implementing high-impact insertion bundles, universal decolonization protocols, and sharps safety controls to eliminate preventable harm and improve institutional patient outcomes. This activity is limited to 120 participants. No prerequisites are required. At the conclusion of this program participants should be able to: 1. Strengthen infection prevention practices by reviewing current evidence and strategies to reduce Bacteremia/CA-BSI and CAUTIs in clinical settings. 2. Improve antimicrobial use and patient outcomes by applying core principles of Antibiotic Stewardship and identifying practical steps to implement or enhance stewardship efforts. 3. Advance a culture of safety and harm reduction by learning best practices for Universal Decolonization, Sharps Safety, and understanding the implications of harm related to HAIs.

DISCLOSURE AND MITIGATION The CAMC Institute for Academic Medicine controls the content and production of this CE activity and attempts to ensure the presentation of balanced, objective information. In accordance with the Standards for Integrity and Independence in Accredited Continuing Education established by the ACCME, faculty, abstract reviewers, paper presenters/authors, planning committee members, staff and any others involved in planning the educational content must disclose any relationship they or their co-authors have with ineligible companies which may be related to their content. The ACCME defines "relevant financial relationships" as financial relationships in any amount occurring within the past 24 months that create a conflict of interest. All presenters, planning committee and faculty have declared no financial interest with an ineligible company for this educational activity.